Intellectual Property India Publishes Patent Application for Antibody-Drug Conjugate Comprising An Anti-Gucy2c Antibody As Well As Methods Of Production And Uses Thereof

MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202647082997 A) filed by Heidelberg Pharma Research Gmbh on July 06, 2026, for Antibody-Drug Conjugate Comprising An Anti-Gucy2c Antibody As Well As Methods Of Production And Uses Thereof.

Inventors include Mller, Christoph; Gruss, Hendrik; Hechler, Torsten; Plfi, Anik; and Schmitt, Marisa.

The application for the patent was published on July 10, 2026, under issue no. 28/2026.

Abstract: The present disclosure relates to new antibody-drug-conjugates (ADCs) comprising a favorable modular linker linking the pharmaceutically active drug substance with the antibody. The present disclosure further relates to methods of producing the antibody- drug conjuga...